Sentences with phrase «in schizophrenia treatment»

Medications are vital in schizophrenia treatment.

Dr. Robert Buchanan of the Maryland Psychiatric Research Center reported on several promising cognitive enhancers that are being clinically tested for their use in schizophrenia treatment.

Not exact matches

ALKS 3831 is a treatment for schizophrenia that avoids the side effects of weight gain and metabolic problems that the incumbent drug has, and a phase 3 trial for it should read out in the fall of 2018.

I am a clinical psychologist who specializes in the treatment of individuals who have been diagnosed with bipolar disorder, schizophrenia, and other severe mental health disorders.

In addition to the new work's potential for RS, there is speculation that it could pave the way to treatments for other neurological disorders, such as learning disabilities, schizophrenia, autism and newborn encephalopathy as well as some mental retardation that has also been linked to the Mecp2 gene.

Although treatments may be years away, identifying this potential molecular mechanism in schizophrenia provides a starting point.

Doctors in Italy first used electroconvulsive therapy in 1938 to treat schizophrenia; in the decades that followed, the treatment spread to other countries and other disorders, especially depression.

Advances in our understanding of the biological pathways and mechanisms involved will help uncover new targets for treatment, which could one day translate into better, more personalised care for people living with schizophrenia.»

Professor Sir Mike Owen, who leads the MRC Centre at Cardiff University, said: «These findings are another important step on the long road to new treatments for schizophrenia and will be crucial for identifying potential new drugs, which will become an increasing focus of our work in the coming years.»

Understanding the function of this gene — described this month in journal Molecular Psychiatry — could lead to more effective treatments for schizophrenia.

At the moment, schizophrenia treatment tends to involve drugs that dampen down neuron activity in the brain.

If the findings can be replicated in larger studies, it might be possible for doctors to identify which people will later develop schizophrenia, and offer them preventative treatments, he says.

When this article was first published, the curves in the graph showing the numbers of people not having relapses of schizophrenia, with standard drug treatment and with minimal treatment, were reversed.

After his six - month trial ended, however, several patients in the treatment group became psychotic, raising the question of whether the treatment was preventing schizophrenia or simply controlling its symptoms.

When the study wrapped up four years later, Falloon found that the incidence of schizophrenia in the treatment zones was one - tenth of what it had been a decade earlier.

For example, a participant with schizophrenia may have mild depressive symptoms that are not accounted for in the treatment plan.

Lately, the drug has also been in the news as a possible treatment for schizophrenia, after psychotic symptoms disappeared in a young Japanese man treated with the antibiotic for pneumonia.

This approach has been used in other brain disorders, such as schizophrenia, which has already led to novel insights and alternative treatment approaches in that disorder.

An ever widening gap is appearing between clinical practice and the treatment prescribed in DSM - 5, the standard work on schizophrenia, psychiatrist Jan Dirk Blom will assert in his inaugural lecture on 11 November.

Fish oil supplements have been investigated as a treatment for adults with schizophrenia, but so far results have been mixed — four trials found no benefit while another four found a small reduction in symptoms.

Although exercise has been shown to be an effective treatment for people with long - term schizophrenia, no studies have assessed its effects on psychiatric symptoms in young adults with early psychosis, until now.

But Perron is emphatic: Although the research looks promising, especially for use in MS, a lot still needs to be done until we can see this as a general treatment for schizophrenia or MS.

«As we develop drugs that work by targeting the primary brain pathology in schizophrenia, it is likely that the differences between patients are going to play a bigger role in determining optimal treatment,» commented Dr. John Krystal, Editor of Biological Psychiatry.

Published May 4, 2015, in Nature Neuroscience, the new findings may eventually lead to treatment strategies targeted for the underlying causes of schizophrenia and related disorders, said the study's corresponding author Scott Soderling, an associate professor of cell biology and neurobiology in the Duke School of Medicine.

«Cold water in the left ear significantly increased patients» insight and awareness of their schizophrenia, which we measured 30 minutes after the test, compared with the sham or placebo treatment using room temperature water,» says Dr. Gerretsen.

«While it still may be possible to optimize GlyT - 1 inhibition as a treatment, these negative results suggest GlyT - 1 inhibition is not a broadly effective or optimal therapeutic strategy to enhance NMDA glutamate receptor function in schizophrenia.»

Researchers randomly selected 801 veterans undergoing treatment for schizophrenia at Veterans Health Administration medical centers in California, New York, Louisiana and Texas.

Because despite the advances in understanding autism and schizophrenia, treatment is limited and difficult, and a cure remains elusive.

Drugs that target neuregulin 3 could help restore glutamate levels in certain types of neurons — a novel approach to schizophrenia treatment.

Despite the fact that schizophrenia affects around 24 million people worldwide, treatment has not changed much in over 50 years, and largely relies on correcting the regulation of dopamine in the brain of schizophrenia sufferers.

Now, by dampening the activity of a small group of neurons deep within the mouse brain, researchers have produced cognitive deficits similar to those found in those with schizophrenia, a discovery that they say could potentially lead to new treatments for the disorder, which affects roughly 24 million people worldwide.

In addition, she said, the data suggest new avenues of treatment for disorders that have social behavior deficits, from autism to schizophrenia or dementia.

The FDA has approved antipsychotics for treatment of certain mental disorders, particularly schizophrenia and bipolar disorder, yet the majority of the people in the study had no such diagnosis.

Antipsychotic medications, a mainstay of treatment for schizophrenia, alleviated some of the animals» symptoms.In the new study, Soderling, postdoctoral researcher Il Hwan Kim, and their team characterized three brain abnormalities in the Arp2 / 3 mice that also appear in people with schizophrenia.

Treatments for schizophrenia have not advanced in more than 50 years, since the discovery of drugs that reduce the activity of the chemical messenger dopamine.

Aberrant intrinsic brain activity and cognitive deficit in first - episode treatment - naive patients with schizophrenia.

As roughly 1 in 10 people with schizophrenia die from suicide, predominantly in the first few years after the illness starts, a treatment that prevents the full illness could save many lives as well as alleviating suffering.»

This is essential in order for us to understand how cannabis increases the risk of schizophrenia and to develop new treatments for people who have the condition and / or a problem with their cannabis use, both in terms of new medicines and better talking therapies.»

Most recently, they have shown that by pharmacologically restoring NMDAR function in these «schizophrenic» mice, their structural, neurochemical, and cognitive deficits can be reversed, pointing to new strategies for more effective treatments for schizophrenia and potentially other serious mental illnesses.

The lab has shown that when NMDAR function is impaired by a genetic mutation, they can recreate, in the mouse, the structural, neurochemical, and functional alterations in the brain that are characteristic of schizophrenia — for example, cognitive and memory impairments for which there are currently no effective treatments.

She integrates morphological and biochemical analysis and state - of - the - art techniques in optogenetic and electrophysiology to better characterize the pathological condition of schizophrenia and develop clinical treatments.

Researchers here are advancing understanding of autism, addiction and mood disorders, improving the treatment of Parkinson's disease, Alzheimer's disease and schizophrenia, and finding new ways to help children succeed in school.

Woolley says studies of the drug are in their infancy, but he holds out hope that oxytocin could become a novel treatment for the social isolation and flat affect so characteristic of schizophrenia.

Studies that would be very difficult to carry out in humans, both from a technical and an ethical point of view can be done with animal models which have proved to be important tools for studying the symptoms, development and treatment of schizophrenia.

Dr. Rapoport was a pioneer in studying the pathophysiology of ADHD and neuropharmacological approaches to its treatment, and she was the first to discover that some childhood psychiatric symptoms result from autoimmune reactions to streptococcal infection, the first to establish the link between obsessive - compulsive behaviors in children and OCD in adults, and the first to use longitudinal magnetic resonance imaging to uncover developmental abnormalities in brain size and structure in children with schizophrenia.

In rats, treatment with certain dopaminergic drugs causes a disruption of PPI similar to that seen in those who have schizophreniIn rats, treatment with certain dopaminergic drugs causes a disruption of PPI similar to that seen in those who have schizophreniin those who have schizophrenia.

«The wealth of new findings have the potential to kick - start the development of new treatments in schizophrenia, a process which has stalled for the last 60 years.»

Below is a list of clinics around the world that specialize in early diagnosis and treatment for schizophrenia and psychosis (delusions, etc).

«However, for women suffering from schizophrenia, bipolar disorder, or major depressive disorder, avoiding medication use is often impossible, given that there are very few alternative treatment options,» she said in a hospital news release.

But new research from James Cook University discovered a potential new use for this way of eating — besides helping you make lean gains, the ketogenic diet could help in the treatment of schizophrenia.